Reference
Boyer S, et al. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. PharmacoEconomics-Open : 4 Jul 2019. Available from: URL: https://doi.org/10.1007/s41669-019-0157-9
Rights and permissions
About this article
Cite this article
Assessing cost effectiveness of second-line HIV regimens in Africa. PharmacoEcon Outcomes News 832, 5 (2019). https://doi.org/10.1007/s40274-019-6031-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6031-2